The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...

Madrigal has made three in-licensing deals since July 2025, picking up multiple potential MASH therapeutics. Read why MDGL ...

The remote control doesn’t trigger the self-destruction of the CAR T cells, but simply prompts them to disengage from their cancerous targets.

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...

A new CAR T therapy design uses the approved drug venetoclax to temporarily disengage engineered immune cells from tumors.

Scripps Research scientists have re-engineered fentanyl’s core structure to retain potent analgesia while limiting respiratory depression in preclinical tests – a strategy that could inform ...

Bacteria in the gut may influence how GLP-1 receptor agonists work. This could help explain why patients do not respond ...

Semaglutide, the active ingredient behind blockbuster weight-loss drugs like Wegovy, is now at the center of a growing body ...

This part of the brain is responsible for self-control, problem-solving, and flexible thinking, and it is often weakened by ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...